NCT01796678View on ClinicalTrials.gov

Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Vaso-occlusive Pain Episodes
Interventions
DRUG

Arginine

DRUG

Placebo

Saline or Sugar pill was given as placebo

Trial Locations (1)

94609

Childrens Hospital Research Center Oakland, Oakland

All Listed Sponsors
lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT01796678 - Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial | Biotech Hunter | Biotech Hunter